Which Live Vaccines Should You Postpone with Cosentyx?
Cosentyx (secukinumab) suppresses the immune system by targeting IL-17A, increasing infection risk. Live vaccines are contraindicated during treatment and for several weeks after stopping. Postpone these until at least 4-6 weeks after your last dose, as antibodies may persist longer.[1][2]
Common examples to avoid:
- MMR (measles, mumps, rubella)
- Varicella (chickenpox/shingles)
- Oral polio, rotavirus, or yellow fever vaccines
- Live nasal flu vaccine (FluMist)
What About Inactivated or Non-Live Vaccines?
These are generally safe and recommended. Get them before starting Cosentyx if possible:
- Inactivated flu shot
- Tdap (tetanus, diphtheria, pertussis)
- Pneumococcal (PCV13, PPSV23)
- HPV, hepatitis A/B, meningococcal vaccines
Complete vaccinations 4 weeks before initiating Cosentyx to maximize response.[1][3]
Timing for Starting or Restarting Vaccines
| Scenario | Recommendation |
|----------|----------------|
| Before Cosentyx | Finish all vaccines 4 weeks prior[1] |
| During treatment | Avoid live vaccines; inactivated OK[2] |
| After stopping | Wait 4-6 weeks for live vaccines; test immunity if high-risk[3] |
| Kids on Cosentyx | Consult pediatrician; routine inactivated shots usually fine[1] |
Why the Live Vaccine Restriction?
Cosentyx impairs immune response to live attenuated viruses, risking uncontrolled replication or vaccine-derived disease. No such issue with killed/subunit vaccines.[2]
Patient and Doctor Considerations
Discuss with your rheumatologist or dermatologist, especially if travel requires vaccines like typhoid (live oral version risky). Recent CDC/ACIP guidelines align with these, but check for updates amid COVID/flu seasons. No major interactions with mRNA COVID boosters reported.[3]
Sources
[1]: Cosentyx Prescribing Information (Novartis)
[2]: FDA Label for Secukinumab
[3]: CDC Vaccination Guidelines for Immunocompromised Adults